Introduction
Lower-limb deep-vein thrombosis (DVT) is common. Prospective studies involving rigorously selected patient groups have played a major role in defining the natural history and providing the evidence base for optimum management strategies. [1] [2] [3] [4] [5] [6] However, generalizability of these studies to typical hospital patients with DVT is uncertain, as they excluded substantial numbers of patients, with different inclusion criteria and risk factors for DVT in each study. Several of these risk factors carry significant co-morbidity, such as increased age, heart failure, stroke and in particular malignancy, the presence of which increased risk of death eightfold after DVT in one 8-year follow-up study. 6 In the early 1990s, we noticed that a large number of patients admitted to our unit were intravenous drug users (IDUs), and that a significant number had DVT or arterial injury. 7 There are few systematic data on the numbers of IDUs among DVT patients, while diagnosis and immediate and long-term clinical management in these patients are difficult and poorly defined. The intravenous use of recreational drugs is associated with considerable morbidity, a significant proportion of which may be from the drug itself, 8 transmission of blood-borne disease 9 and localized complications of injecting habits. 10 The aim of this study was to obtain a profile of DVT patients in a routine district general hospital setting, examining risk factors, presentation, management and outcome of a retrospective-identified patient group diagnosed with lower-limb DVT over a year. We also hoped to determine the overall contribution of IV drug use to lower-limb DVT and to highlight problems in management of IDU. Difficulties in extracting records of DVT patients from our hospital system were also identified. At the time of this study, patients with both proximal and distal DVT were managed as in-patients.
Methods
The medical records of all patients with lower-limb DVT discharged from University Hospital Aintree in 1996 were reviewed. To maximize patient ascertainment, three sets of patient lists were used: hospital computer records of discharge diagnoses, radiology departmental lists of venograms and Doppler ultrasound scans, and accident and emergency admission lists for possible DVT. Episodes were excluded if they were direct presentations of pulmonary embolism (PE, 26 episodes), thrombophlebitis (22 episodes), non-limb venous thrombosis (10 episodes) or upper-limb DVT (5 episodes). Episodes were not considered discrete if the patient was readmitted within 7 days of discharge.
A pre-piloted proforma was used. Data extracted from case records included patient demographics and risk factors, clinical presentation, use of diagnostic procedures, management, outcome, complications and recurrence at 6 months. Patient premorbidity on admission was scored using the Karnofsky Performance Index. 
Results
The hospital computer administration system identified 266 episodes with thrombosis-related discharge diagnoses, of which 184 episodes were lowerlimb DVT. A further 48 episodes were identified from the additional sources (Figure 1 ), 28 (58.3%) of which were hospital-acquired DVT. In total, 232 episodes in 223 patients were studied. The diagnosis of DVT was confirmed in all but seven cases by venography, Doppler ultrasound scanning or autopsy; these seven were diagnosed on clinical criteria alone.
Most DVTs were proximal, and proximal DVT was more common with IDUs and malignancy. There was no difference in distribution between community and hospital acquired cases (Table 1) Patient characteristics and risk factors are summarized in Table 2 . Male:female ratio was 1:1.4, with no difference in mean age between males (61.8 years) and females (63.3 years). There was a bimodal pattern of ages, with peaks seen in the age groups 26-30 and 71-75 years; 98/223 (43.9%) of patients were aged 470 years. Median Karnofsky Performance Index score at presentation was 7 (range 2-10), reflecting 'an inability to carry out normal activity or to do active work', and scores inversely correlated with age (correlation coefficient À0.549, p 5 0.0005). Significant differences in risk factor prevalence between community and hospital presentations are highlighted in Table 2 , although there was no significant difference in the overall number of risk factors (Figure 2 Lower
Comparison with selected prospective studies [1] [2] [3] [4] [5] [6] on clinical course and management (Table 3) demonstrates an under-representation in those studies of patients with previous DVT history, cancer, varicose veins, pregnancy and IV drug use, necessitated largely through study exclusion criteria, while other quoted exclusion criteria (e.g. short life expectancy, bilateral or IVC thromboses, very recent surgery or anaesthesia, bleeding diatheses or nidus, leg paresis, arterial insufficiency or venous ulceration, unavailability for follow-up) would have excluded significant additional numbers.
History of previous DVT was more common in IDUs (46.7%) vs. non-IDUs (21.5%) (p ¼ 0.027) and in patients with thrombophilia (5/6). A history of surgery in the preceding 3 months was found in 40/220 (18.2%) patients, of whom 19 (47.5%) presented following discharge from the operation, constituting 19/168 (11.3%) of community acquired DVTs. A malignancy was present in 36/212 (17.0%), and in these patients multiple risk factors were common, including mean age of 66.8 years, recent surgery in 11/34 (32%), other immobility 7/34 (20.5%), low cardiac output states 5/35 (14.3%) and previous DVT 4/32 (12.5%).
In-patient mortality in our DVT patients was 3.9% (9/232) from DVT-related causes and 6.0% (14/232) from DVT-unrelated causes, while one cause of death was undetermined. Excluding IDUs, the mean (range) age of patients with DVT-unrelated deaths was significantly higher than for those who survived, but the age difference between DVT-related death and survival was not significant (74.0 (50-89) and 73.7 (51-95) vs. 64.1 (25-97) years, p ¼ 0.046 and 0.085, respectively). Risk factors associations with mortality are listed in Table 4 , of which malignancy was the most significant.
The DVT progressed to PE in 15/227 (6.6%), representing 12/164 (7.3%) of community-and 3/63 (4.8%) of hospital-acquired DVT, respectively (p ¼ 0.693). Mortality was 8/15 (53.3%), directly from PE in 5/15 and from DVT-unrelated causes in 3/15, while PE was significantly associated with both DVT-related (5/9, p 5 0.0005) and unrelated There were two extensions to the inferior vena cava and 12 to the iliac veins. Post-thrombotic syndrome (PTS) developed within 6 months in three patients, although a further three presented with existing leg ulcerations and a history of DVT. Bleeds during in-patient anticoagulation were recorded for 17/211 (8.1%) episodes, of which 3/17 (17.6%) were fatal. Bleeds during home anticoagulation were recorded for 4/187 (2.1%) episodes; none was fatal. DVT recurrence was seen in 19/209 (9.1%) surviving episodes at 6 months, and was associated with IDU (6/19, 31.6%, p 5 0.0005) and venous trauma in non-injecting, non-surgical patients (5/18, p ¼ 0.005); no association with malignancy or thrombophilia was demonstrated.
Discussion
Our efforts to identify DVT cases and obtain case notes were extensive. Problems encountered were miscoded hospital computer records (4.9% of episodes) and the confusion or combination of other thrombosis-related diagnoses with DVT (21.8%). The hospital activity index identified only 79.3% of confirmed episodes, as determined by including accident and emergency and radiology indexes. A significant number of missed episodes were hospital-acquired, which were frequently complicated with an array of medical problems, giving rise to coding difficulty. We can speculate over the significance of this finding with respect to other similar studies on DVT, which may have missed these more morbid patients in whom management complications are also more likely. We recommend that future studies on DVT where cases are identified retrospectively use multiple sources.
Radiology departmental records in particular identified a large proportion of the missed cases.
There is a marked difference in the characteristics of this group of patients compared to those used in the prospective studies analysed, indicating the patients used in the evidence-base for formulating DVT management are not representative of those seen in clinical practice. The effect of this can be seen in the difference in overall in-patient mortality rate between this study (9.9%) and randomized controlled trials of DVT treatment ($4%), 12 with a greater number dying of DVT-unrelated causes (6.0%). This is particularly pertinent to the need for subgroup-orientated therapy. 13 There was a high proportion of IDUs in our DVT patients. The association of IV drug misuse with DVT is well recognized. 7, 14 Their representation among hospital DVT patients is less well appreciated, but accounted for 9.6% of all communityacquired DVT and 48.4% of patients aged 540 years in our study. This is similar to a study of women with DVT in Glasgow, where 21% of all DVTs and 52% of those aged 540 years were IDUs.
14 The association of IDU with right-sided DVT has not been described before. Previous studies in non-IDUs have shown proximal DVT to occur more often on the left, with little difference in laterality of distal DVT. 15 IDUs have been universally excluded from the prospective studies we reviewed (personal communications), 1, [3] [4] [5] [6] 16, 17 owing largely to their erratic behaviour. They are often not mentioned in general DVT reviews. 18 Deep-vein thrombosis is one of a number of lower-limb complications of groin injecting 10 and may arise or be complicated by coincident sepsis. 19, 20 With the high rate of recurrence of 31.6% at 6 months, there is increased risk of PTS. Evaluation is additionally complicated by soft-tissue pathology and venous access difficulties, which would hamper diagnostic ultrasonography and venography. Further work is required to define the clinical course, natural history and optimum approach to investigation and treatment of swollen limbs 21 and DVT in this group, especially as a subsequent study in our hospital has confirmed the importance of IDUs over a larger period of time, with high rates of recurrence, irrespective of the type of treatment offered in hospital. 22 Malignancy was present in 17% of patients, and was associated with multiple coincident DVT risk factors. It was the most significant risk factor associated with mortality and, perhaps consequently, was not associated with recurrence.
A significant number of patients were postsurgical, and 46.3% of these presented with DVT from the community following discharge. Risk of DVT may persist for a considerable time following discharge from surgery. 23 The advantage of continuing prophylactic anticoagulation upon discharge to the community with LMWH has been suggested before. 24 Approximately 10% of proximal DVT embolized (86.7% of PE). Mortality from PE was 53.3%, with a third dying from the PE and a fifth from other causes. This is much higher than the 15-17.5% mortality rate quoted for direct presentations of PE, 25 and perhaps indicates the significant morbidity of patients who present with embolization despite adequate anticoagulation therapy.
This study describes DVT as a condition associated with considerable morbidity, much of which is absent from the evidence base used to define best clinical practice management. Intravenous drug use is an important cause of community-acquired DVT in young adults.
